Subarachnoid Hemorrhage
Conditions
Interventions
stent-assisted group:Treat via stent-assisted coiling
Flow diversion group:Treat via Flow diversion
Conservative group:Apply conservative treatment
Other treatments group:Treat via other strategies
Complication group:Gene analysis
None-comlication group:Gene analysis
Normal control group:Gene analysis
Sponsors
Beijing Tiantan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-80 years and diagnosed with subarachnoid hemorrhage; 2. Compplete medical records and imaging data are available; 3. Use conservative or interventional treatment. Genetic analysis research 1. Participate in clinical cohort studies; 2. Patients with and without complications; 3. Normal control group.
Exclusion criteria
Exclusion criteria: 1. Refuse to sign informed consent; 2. Combined with other serious diseases: such as malignant tumors, myocardial infarction, etc.; 3. Combined with other vascular diseases: such as arteriovenous malformations, dural arteriovenous fistula, severe coronary heart disease, etc..
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complication rate;Genetic testing;Prognosis; | — |
Countries
China
Contacts
Public ContactAihua Liu
Beijing Tiantan Hospital, Capital Medical University
Outcome results
None listed